Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes
Clinical trial NCT01159600 · COMPLETED
Trial details
- NCT number
- NCT01159600
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2012-02-01
- Enrollment
- 1504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.